Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$27,000.00

Developing wise practices to enhance First Nations, Inuit, and Métis engagement in culturally safe clinical trials

EF 2024-25

Résumé
Equitable access to clinical trials of innovative treatments for complex health conditions is essential. However, First Nations, Inuit, and Métis (FNIM) peoples in Canada are significantly underrepresented in clinical trials, including cutting-edge cell therapy research. This underrepresentation reduces the relevance of trial findings, reinforces health inequities, and limits access to potentially life-saving treatments. These challenges are rooted in a history of exploitative research practices, which have eroded trust and created systemic barriers to FNIM participation. This project, co-developed with FNIM patient partners, aims to identify culturally safe practices to improve FNIM inclusion in clinical trials. First, we will conduct a systematic review of cell therapy trials to assess FNIM representation and how demographic data is reported. Second, we will engage FNIM patients, families, and clinical trial investigators in culturally informed interviews to explore their perspectives on, and identify barriers and enablers to, FNIM participation in trials. These interviews will use culturally tailored approaches, blending Indigenous sharing circle protocols with Western focus-group methods to create a respectful space for open dialogue and mutual understanding. Study findings will provide actionable recommendations to help researchers design clinical trials that are inclusive, culturally safe, and responsive to FNIM health priorities. Ultimately, this work aims to advance reconciliation efforts by addressing systemic inequities, fostering trust, and improving access to clinical research for FNIM populations while enhancing the diversity and relevance of clinical trial outcomes for all.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530152
Name
McRorie Alexandria B
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Developing wise practices to enhance First Nations, Inuit, and Métis engagement in culturally safe clinical trials
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Access; Cell Therapy; Clinical Trials; Community Engagement; Equity; Indigenous Health; Patient Engagement; Qualitative Research; Systematic Reviews
Abstract
Equitable access to clinical trials of innovative treatments for complex health conditions is essential. However, First Nations, Inuit, and Métis (FNIM) peoples in Canada are significantly underrepresented in clinical trials, including cutting-edge cell therapy research. This underrepresentation reduces the relevance of trial findings, reinforces health inequities, and limits access to potentially life-saving treatments. These challenges are rooted in a history of exploitative research practices, which have eroded trust and created systemic barriers to FNIM participation. This project, co-developed with FNIM patient partners, aims to identify culturally safe practices to improve FNIM inclusion in clinical trials. First, we will conduct a systematic review of cell therapy trials to assess FNIM representation and how demographic data is reported. Second, we will engage FNIM patients, families, and clinical trial investigators in culturally informed interviews to explore their perspectives on, and identify barriers and enablers to, FNIM participation in trials. These interviews will use culturally tailored approaches, blending Indigenous sharing circle protocols with Western focus-group methods to create a respectful space for open dialogue and mutual understanding. Study findings will provide actionable recommendations to help researchers design clinical trials that are inclusive, culturally safe, and responsive to FNIM health priorities. Ultimately, this work aims to advance reconciliation efforts by addressing systemic inequities, fostering trust, and improving access to clinical research for FNIM populations while enhancing the diversity and relevance of clinical trial outcomes for all.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
McRorie, Alexandria B
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~